Skip to content Skip to footer

Loading Results

The role of private equity firms in health



To listen to all PwC Next in Health podcasts, click here. Subscribe and listen to all episodes at your convenience via any device at Apple PodcastsSpotify and Stitcher.

Overview

Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos in discussion with PwC’s Deals Strategy & Pharma and Life Sciences Principal, Claire Love, on what role private equity firms play, in the rapid growth market of gene and cell therapies, including:

  • What are the growth drivers for private equity firms?
  • What technologies and innovations can be leveraged to increase supply chain efficiency?
  • Opportunities and risks private equity firms should consider
  • Improving collaboration between the pharmaceutical industry and private equity investors

Topics: private equity, healthcare, pharmaceutical

Contact us

Benjamin Isgur

Benjamin Isgur

Health Research Institute Leader, PwC US

Trine K. Tsouderos

Trine K. Tsouderos

HRI Regulatory Center Leader, PwC US

Tel: +1 (312) 241 3824

Follow us